Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Международные алгоритмы ведения пациенток с дисплазией шейки матки
Международные алгоритмы ведения пациенток с дисплазией шейки матки
Доброхотова Ю.Э., Боровкова Е.И. Международные алгоритмы ведения пациенток с дисплазией шейки матки. Гинекология. 2018; 20 (5): 27–32.
DOI: 10.26442/2079-5696_2018.5.27-32
DOI: 10.26442/2079-5696_2018.5.27-32
DOI: 10.26442/2079-5696_2018.5.27-32
________________________________________________
DOI: 10.26442/2079-5696_2018.5.27-32
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье представлены алгоритмы ведения пациенток в зависимости от результатов мазка на онкоцитологию и в соответствии с возрастом пациентки.
Ключевые слова: дисплазия шейки матки, беременность, рак шейки матки, онкоцитология, вирус папилломы человека.
Key words: cervical dysplasia, pregnancy, cervical cancer, onco-cytology, human papillomavirus.
Ключевые слова: дисплазия шейки матки, беременность, рак шейки матки, онкоцитология, вирус папилломы человека.
________________________________________________
Key words: cervical dysplasia, pregnancy, cervical cancer, onco-cytology, human papillomavirus.
Полный текст
Список литературы
1. Sabatino SA, White MC, Thompson TD et al. Cancer screening test use – United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64: 464.
2. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013; 2: 35.
3. Whitlock EP, Vesco KK, Eder M et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 687.
4. Massad LS, Einstein MH, Huh WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829.
5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010; 116: 469.
6. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62: 147.
7. Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012; 120: 1222.
8. Huh WK, Ault KA, Chelmow D et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol 2015; 125: 330.
9. Wright TC, Stoler MH, Behrens CM et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015; 136: 189.
10. Perkins RB, Stier EA. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Ann Intern Med 2014; 161: 295.
11. Dilley SE, O'Donnell JA, Smith HJ et al. Scientific Plenary: Rethinking cervical cancer screening guidelines in an aging U.S. population. University of Alabama at Birmingham, Birmingham, AL, USA. https://www.sgo.org/wp-content/uploads/2018/03/Abstracts-2018-SGO-Annual-Meeting-on-Womens-Cancer-1....
12. White MC, Shoemaker ML, Benard VB. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening. Am J Prev Med 2017; 53: 392.
13. Andrae B, Andersson TM, Lambert PC et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.
14. American Society for Colposcopy and Cervical Pathology. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 2009 addendum. www.guideline.gov/summary/summary.aspx?doc_id=14698&nbr=007268&string=HPV
15. FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm
16. Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880.
17. Amant F, Halaska MJ, Fumagalli M et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394.
18. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008; 199: 3.
19. Morimura Y, Fujimori K, Soeda S et al. Cervical cytology during pregnancy – comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27.
20. Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678.
21. Committee on Practice Bulletins – Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016; 128: e111. Reaffirmed 2018.
22. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 2006; 17: 127.
2. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013; 2: 35.
3. Whitlock EP, Vesco KK, Eder M et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 687.
4. Massad LS, Einstein MH, Huh WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829.
5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010; 116: 469.
6. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62: 147.
7. Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012; 120: 1222.
8. Huh WK, Ault KA, Chelmow D et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol 2015; 125: 330.
9. Wright TC, Stoler MH, Behrens CM et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015; 136: 189.
10. Perkins RB, Stier EA. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Ann Intern Med 2014; 161: 295.
11. Dilley SE, O'Donnell JA, Smith HJ et al. Scientific Plenary: Rethinking cervical cancer screening guidelines in an aging U.S. population. University of Alabama at Birmingham, Birmingham, AL, USA. https://www.sgo.org/wp-content/uploads/2018/03/Abstracts-2018-SGO-Annual-Meeting-on-Womens-Cancer-1....
12. White MC, Shoemaker ML, Benard VB. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening. Am J Prev Med 2017; 53: 392.
13. Andrae B, Andersson TM, Lambert PC et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.
14. American Society for Colposcopy and Cervical Pathology. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 2009 addendum. www.guideline.gov/summary/summary.aspx?doc_id=14698&nbr=007268&string=HPV
15. FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm
16. Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880.
17. Amant F, Halaska MJ, Fumagalli M et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394.
18. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008; 199: 3.
19. Morimura Y, Fujimori K, Soeda S et al. Cervical cytology during pregnancy – comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27.
20. Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678.
21. Committee on Practice Bulletins – Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016; 128: e111. Reaffirmed 2018.
22. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 2006; 17: 127.
2. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013; 2: 35.
3. Whitlock EP, Vesco KK, Eder M et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 687.
4. Massad LS, Einstein MH, Huh WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829.
5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010; 116: 469.
6. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62: 147.
7. Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012; 120: 1222.
8. Huh WK, Ault KA, Chelmow D et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol 2015; 125: 330.
9. Wright TC, Stoler MH, Behrens CM et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015; 136: 189.
10. Perkins RB, Stier EA. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Ann Intern Med 2014; 161: 295.
11. Dilley SE, O'Donnell JA, Smith HJ et al. Scientific Plenary: Rethinking cervical cancer screening guidelines in an aging U.S. population. University of Alabama at Birmingham, Birmingham, AL, USA. https://www.sgo.org/wp-content/uploads/2018/03/Abstracts-2018-SGO-Annual-Meeting-on-Womens-Cancer-1....
12. White MC, Shoemaker ML, Benard VB. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening. Am J Prev Med 2017; 53: 392.
13. Andrae B, Andersson TM, Lambert PC et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.
14. American Society for Colposcopy and Cervical Pathology. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 2009 addendum. www.guideline.gov/summary/summary.aspx?doc_id=14698&nbr=007268&string=HPV
15. FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm
16. Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880.
17. Amant F, Halaska MJ, Fumagalli M et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394.
18. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008; 199: 3.
19. Morimura Y, Fujimori K, Soeda S et al. Cervical cytology during pregnancy – comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27.
20. Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678.
21. Committee on Practice Bulletins – Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016; 128: e111. Reaffirmed 2018.
22. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 2006; 17: 127.
________________________________________________
2. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev 2013; 2: 35.
3. Whitlock EP, Vesco KK, Eder M et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155: 687.
4. Massad LS, Einstein MH, Huh WK et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121: 829.
5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010; 116: 469.
6. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62: 147.
7. Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012; 120: 1222.
8. Huh WK, Ault KA, Chelmow D et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstet Gynecol 2015; 125: 330.
9. Wright TC, Stoler MH, Behrens CM et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015; 136: 189.
10. Perkins RB, Stier EA. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Ann Intern Med 2014; 161: 295.
11. Dilley SE, O'Donnell JA, Smith HJ et al. Scientific Plenary: Rethinking cervical cancer screening guidelines in an aging U.S. population. University of Alabama at Birmingham, Birmingham, AL, USA. https://www.sgo.org/wp-content/uploads/2018/03/Abstracts-2018-SGO-Annual-Meeting-on-Womens-Cancer-1....
12. White MC, Shoemaker ML, Benard VB. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening. Am J Prev Med 2017; 53: 392.
13. Andrae B, Andersson TM, Lambert PC et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.
14. American Society for Colposcopy and Cervical Pathology. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 2009 addendum. www.guideline.gov/summary/summary.aspx?doc_id=14698&nbr=007268&string=HPV
15. FDA approves first human papillomavirus test for primary cervical cancer screening. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm
16. Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156: 880.
17. Amant F, Halaska MJ, Fumagalli M et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014; 24: 394.
18. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008; 199: 3.
19. Morimura Y, Fujimori K, Soeda S et al. Cervical cytology during pregnancy – comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48: 27.
20. Moscicki AB, Shiboski S, Hills NK et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678.
21. Committee on Practice Bulletins – Gynecology. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016; 128: e111. Reaffirmed 2018.
22. Coleman DV, Poznansky JJ. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications. Cytopathology 2006; 17: 127.
Авторы
Ю.Э.Доброхотова, Е.И.Боровкова*
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*katyanikitina@mail.ru
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*katyanikitina@mail.ru
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И.Пирогова» Минздрава России. 117997, Россия, Москва, ул. Островитянова, д. 1
*katyanikitina@mail.ru
________________________________________________
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
*katyanikitina@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.